Page last updated: 2024-12-06

oxetorone

Description Research Excerpts Clinical Trials Roles Classes Pathways Study Profile Bioassays Related Drugs Related Conditions Protein Interactions Research Growth Market Indicators

Description

Oxetorone is a potent and selective 5-HT3 receptor antagonist. It is structurally similar to ondansetron, another 5-HT3 antagonist used to treat nausea and vomiting. However, oxetorone exhibits greater potency and selectivity for the 5-HT3 receptor, potentially leading to improved efficacy and reduced side effects. Its synthesis typically involves modifications to the ondansetron molecule to enhance its affinity and selectivity for the target receptor. Research on oxetorone focuses on its potential therapeutic applications in treating various conditions, including chemotherapy-induced nausea and vomiting, irritable bowel syndrome, and anxiety. The compound's ability to modulate the serotonin system, specifically the 5-HT3 receptor, makes it a promising candidate for these indications.'

oxetorone: treatment of migraine; RN given refers to parent cpd; structure [Medical Subject Headings (MeSH), National Library of Medicine, extracted Dec-2023]

Cross-References

ID SourceID
PubMed CID36846
CHEMBL ID3989752
CHEBI ID135364
MeSH IDM0058635

Synonyms (21)

Synonym
oxetorone
CHEBI:135364
26020-55-3
unii-t3xos33tiq
3-(12h-benzofuro(3,2-c)(1)benzoxepin-6-yliden)-n,n-dimethylpropylamin
oxetoronum [inn-latin]
oxetoronum
n,n-dimethylbenzofuro(3,2-c)(1)benzoxepin-delta6(12h),gamma-propylamine
oxetorona
oxetorona [inn-spanish]
einecs 247-411-3
t3xos33tiq ,
oxetorone [inn]
1-propanamine, 3-benzofuro(3,2-c)(1)benzoxepin-6(12h)-ylidene-n,n-dimethyl-
n,n-dimethylbenzofuro(3,2-c)(1)benzoxepin-d6(12h),g-propylamine
oxetorone [mi]
oxetorone [who-dd]
3-(12h-[1]benzofuro[3,2-c][1]benzoxepin-6-ylidene)-n,n-dimethylpropan-1-amine
CHEMBL3989752
3-([1]benzofuro[3,2-c][1]benzoxepin-6(12h)-ylidene)-n,n-dimethylpropan-1-amine
DTXSID50865262

Research Excerpts

Overview

Oxetorone is a serotonin antagonist antimigraine drug. Literature relating to its toxic properties is poor.

ExcerptReferenceRelevance
"Oxetorone is a serotonin antagonist antimigraine drug but literature relating to its toxic properties is poor. "( New evidence for oxetorone toxicity.
Bruneau, C; Deguigne, M; Le Roux, G; Touré, A; Turcant, A, 2017
)
2.24
[information is derived through text-mining from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Drug Classes (1)

ClassDescription
oxacycleAny organic heterocyclic compound containing at least one ring oxygen atom.
[compound class information is derived from Chemical Entities of Biological Interest (ChEBI), Hastings J, Owen G, Dekker A, Ennis M, Kale N, Muthukrishnan V, Turner S, Swainston N, Mendes P, Steinbeck C. (2016). ChEBI in 2016: Improved services and an expanding collection of metabolites. Nucleic Acids Res]

Research

Studies (15)

TimeframeStudies, This Drug (%)All Drugs %
pre-19907 (46.67)18.7374
1990's4 (26.67)18.2507
2000's2 (13.33)29.6817
2010's2 (13.33)24.3611
2020's0 (0.00)2.80
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Market Indicators

Research Demand Index: 33.91

According to the monthly volume, diversity, and competition of internet searches for this compound, as well the volume and growth of publications, there is estimated to be moderate demand-to-supply ratio for research on this compound.

MetricThis Compound (vs All)
Research Demand Index33.91 (24.57)
Research Supply Index3.04 (2.92)
Research Growth Index4.17 (4.65)
Search Engine Demand Index42.51 (26.88)
Search Engine Supply Index2.00 (0.95)

This Compound (33.91)

All Compounds (24.57)

Study Types

Publication TypeThis drug (%)All Drugs (%)
Trials3 (17.65%)5.53%
Reviews1 (5.88%)6.00%
Case Studies7 (41.18%)4.05%
Observational1 (5.88%)0.25%
Other5 (29.41%)84.16%
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]